These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6307549)

  • 1. Suppressive effect of metyrapone on plasma corticotrophin immunoreactivity in normal man.
    Schöneshöfer M; Fenner A; Claus M
    Clin Endocrinol (Oxf); 1983 Apr; 18(4):363-70. PubMed ID: 6307549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyrapone.
    Mune T; Morita H; Yasuda K; Murayama M; Yamakita N; Miura K
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):265-72. PubMed ID: 8384536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metyrapone induced increase in plasma corticotropin is not associated with changes in peripheral venous arginine vasopressin or corticotropin releasing factor.
    Holmes SJ; Florkowski CM; Evans MJ; Ellis MJ; Livesey JH; Donald RA; Espiner EA
    J Endocrinol Invest; 1993 Nov; 16(10):787-92. PubMed ID: 8144852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overnight ACTH-cortisol dose responsiveness: comparison with 24-h data, metyrapone administration and insulin-tolerance test in healthy adults.
    Iranmanesh A; Keenan DM; Aoun P; Veldhuis JD
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):596-601. PubMed ID: 21609353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ACTH response to oral and intravenous metyrapone by antiserotoninergic treatment in man.
    Cavagnini F; Panerai AE; Valentini F; Bulgheroni P; Peracchi M; Pinto M
    J Clin Endocrinol Metab; 1975 Jul; 41(1):143-8. PubMed ID: 168228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-sites of inhibition by intravenous metyrapone of human adrenal steroidogenesis.
    Schöneshöfer M; Claus M
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):378-85. PubMed ID: 2992206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
    Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discrepancy between plasma 11-deoxycortisol and ACTH concentrations in a single dose metyrapone test in normal men.
    Matsuki M; Nishida S; Horino M; Tenku A; Oyama H
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):62-5. PubMed ID: 6289591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
    Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease.
    Arvat E; Ramunni J; Maccagno B; Giordano R; Broglio F; Deghenghi R; Boscaro M; Ghigo E
    Neuroendocrinology; 1999 Sep; 70(3):200-6. PubMed ID: 10516483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function.
    Kamilaris TC; DeBold CR; Pavlou SN; Island DP; Hoursanidis A; Orth DN
    J Clin Endocrinol Metab; 1987 Nov; 65(5):994-9. PubMed ID: 3499449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism.
    Soule S; Van Zyl Smit C; Parolis G; Attenborough S; Peter D; Kinvig S; Kinvig T; Coetzer E
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):221-7. PubMed ID: 10931104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone secretion and corticotropin-releasing factor gene expression in the paraventricular nucleus of rhesus monkeys following cortisol synthesis inhibition.
    Van Vugt DA; Piercy J; Farley AE; Reid RL; Rivest S
    Endocrinology; 1997 Jun; 138(6):2249-58. PubMed ID: 9165008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of adrenocorticotropin and adrenal steroid responses to corticotropin-releasing hormone versus metyrapone testing in patients with hypopituitarism.
    Riddick L; Chrousos GP; Jeffries S; Pang S
    Pediatr Res; 1994 Aug; 36(2):215-20. PubMed ID: 7970937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intrafetal infusion of metyrapone on arterial blood pressure and on the arterial blood pressure response to angiotensin II in the sheep fetus during late gestation.
    Warnes KE; Coulter CL; Robinson JS; McMillen IC
    J Physiol; 2003 Oct; 552(Pt 2):621-33. PubMed ID: 14561842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man.
    Hensen J; Hader O; Bähr V; Oelkers W
    J Clin Endocrinol Metab; 1988 Apr; 66(4):668-71. PubMed ID: 2831245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction.
    Donald RA; Crozier IG; Foy SG; Richards AM; Livesey JH; Ellis MJ; Mattioli L; Ikram H
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):499-504. PubMed ID: 8187316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metyrapone: an agent for melatonin as well as ACTH and cortisol secretion.
    Brismar K; Werner S; Thorén M; Wetterberg L
    J Endocrinol Invest; 1985 Apr; 8(2):91-5. PubMed ID: 2993405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.